Estrella Immunopharma
$0.07
0
-$0-0.27% Monday 16:31
Statistics
Day High
0.07
Day Low
0.07
52W High
0.07
52W Low
0.07
Volume
1,605
Avg. Volume
-
Mkt Cap
2.83M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
3JunExpected
Expected EPS
-0.18
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-26.86MNet Income
Analyst Ratings
$8.00Average Price Target
The highest estimate is 8.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ESLAW. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.
Show more...
CEO
Dr. Cheng Liu Ph.D.
Country
US
ISIN
US2975841121
Listings
0 Comments
Share your thoughts
FAQ
What is Estrella Immunopharma stock price today?▼
The current price of ESLAW is $0.07 USD — it has decreased by -0.27% in the past 24 hours. Watch Estrella Immunopharma stock price performance more closely on the chart.
What is Estrella Immunopharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Estrella Immunopharma stocks are traded under the ticker ESLAW.
What is Estrella Immunopharma market cap?▼
Today Estrella Immunopharma has the market capitalization of 2.83M
When is the next Estrella Immunopharma earnings date?▼
Estrella Immunopharma is going to release the next earnings report on June 03, 2026.
What were Estrella Immunopharma earnings last quarter?▼
ESLAW earnings for the last quarter are -0.16 USD per share, whereas the estimation was -0.18 USD resulting in a +11.11% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Estrella Immunopharma revenue for the last year?▼
Estrella Immunopharma revenue for the last year amounts to 0 USD.
What is Estrella Immunopharma net income for the last year?▼
ESLAW net income for the last year is -26.86M USD.
In which sector is Estrella Immunopharma located?▼
Estrella Immunopharma operates in the Health Care sector.
When did Estrella Immunopharma complete a stock split?▼
Estrella Immunopharma has not had any recent stock splits.
Where is Estrella Immunopharma headquartered?▼
Estrella Immunopharma is headquartered in EmeryVille, US.